News

October 19, 2022

Professor Chris Pemberton wins Translational Research Award

We are delighted with the news that founder and CSO, Professor Chris Pemberton, along with Ms Sarah Raudsepp, and his multi-disciplinary team of professors from Otago University, are the recipients of this year’s $50,000 University of Otago Translational Research Award for their work in developing a new method for rapidly diagnosing heart attacks.

Read the University of Otago article

‍

Share this post

More Articles

Detecting at-risk heart attack patients, a step closer with $2m investment

Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.

Upstream commences testing Marker C on the APACE cohort

The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort.

December 12, 2022

Analysis of Marker C in clinical triage protocols available

By shifting chest pain patients with intermediate troponins to low or high-risk categories, Marker C could rapidly triage 10-35% more chest pain patients in the emergency department.

Connect with us

info@upstreamdx.com

Auckland, New Zealand